Study examined machine learning for predicting response to treatment in non-Hodgkin lymphomas.
Home / Resource Library / Prospective Clinical Validation of a Combinatorial Functional Precision Medicine Platform in Relapsed/Refractory Non-Hodgkin Lymphoma